Document And Entity Information Document Type Document Quarterly Report Document Period End Date Document Transition Report Securities Act File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag Consolidated Balance Sheets Statement [Table] Statement [Line Items] Statement Assets [Abstract] Assets Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Accounts Receivable, after Allowance for Credit Loss, Current Accounts receivable Inventory, Net Inventory Total Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current Total current assets Operating Lease, Right-of-Use Asset Operating leases, Right-of-use asset Operating lease right-of-use assets, net Equity Method Investments Equity method investment Other Assets, Noncurrent Other assets Assets Total assets Liabilities and Equity [Abstract] Liabilities and stockholders' deficit Liabilities, Current [Abstract] Current liabilities: Convertible Notes Payable, Current Current portion of unsecured convertible promissory note The portion of the carrying value of long-term unsecured promissory note as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible Unsecured Promissory Note is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. Unsecured Promissory Note, Current Current portion of unsecured promissory note Operating Lease, Liability, Current Current portion of operating lease liabilities Accounts Payable, Current Accounts payable Accrued Liabilities, Current Total accrued expenses Accrued expenses Accrued Income Taxes, Current Income taxes payable Liabilities, Current Total current liabilities Notes and Loans, Noncurrent Unsecured promissory note Long-term debt Operating Lease, Liability, Noncurrent Operating lease liabilities Warrants and Rights Outstanding Warrant liability Liabilities Total liabilities Commitments and Contingencies. Commitments and contingencies (Note 8) Equity, Attributable to Parent [Abstract] Stockholders' deficit: Preferred Stock, Value, Issued Preferred stock, par value $0.01 per share: 10,000,000 shares authorized, no shares issued and outstanding Common Stock, Value, Issued Common stock, par value $0.01 per share; 260,000,000 shares authorized; 187,096,998 and 53,887,233 shares issued and outstanding at June 30, 2026 and September 30, 2025, respectively Additional Paid in Capital, Common Stock Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Equity, Attributable to Parent Balance, ending Balance, beginning Total stockholders' deficit Liabilities and Equity Total liabilities and stockholders' deficit Preferred Stock, Par or Stated Value Per Share Preferred stock, par value per share (in dollars per share) Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred Stock, Shares Issued Preferred stock, shares issued Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Common Stock, Par or Stated Value Per Share Common stock, par value per share (in dollars per share) Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Balance, ending (in shares) Balance, beginning (in shares) Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding Consolidated Statements of Operations Amount from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Revenues From Contract with Customer, Net Revenues, net Cost of Goods and Services Sold Cost of revenues Gross Profit Gross profit Operating Expenses [Abstract] Operating expenses: Operating expenses: Research and Development Expense Research and development Research and Development Expense, Total Selling, General and Administrative Expense Selling, general and administrative Total selling, general and administrative expenses Operating Income (Loss) Loss from operations Income (Loss) from Equity Method Investments Loss (Gain) on equity method investment Interest Income (Expense), Operating Interest (income) expense, net Amount of expense (income) related to adjustment to fair value of redemption feature. Change In Fair Value Of Redemption Feature Loss (Gain) from change in fair value of promissory notes Loss from change in fair value of promissory notes Amount of charge recognized during the period on remeasurement of warrants. Warrant Inducement Charge On Remeasurement Warrant inducement expenses Fair Value Adjustment of Warrants (Gain) loss from change in fair value of warrant liability Loss (Gain) from change in fair value of warrant liability Gain (Loss) on Extinguishment of Debt (Gain) loss on extinguishment of debt Loss on extinguishment of debt Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Net loss before income taxes Income Tax Expense (Benefit) Income tax expense Net Income (Loss) Available to Common Stockholders, Basic Net loss Net loss attributable to common stockholders Earnings Per Share [Abstract] Per share information: Basic and diluted earnings per share: Earnings Per Share, Basic Basic net loss per share (in dollars per share) Loss per share of common stock, basic (in dollars per share) Earnings Per Share, Diluted Diluted net (loss) income per share (in dollars per share) Loss per share of common stock, diluted (in dollars per share) Weighted Average Number of Shares Outstanding, Basic Weighted average shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Diluted Weighted average shares outstanding, diluted (in shares) Consolidated Statements of Stockholders' Deficit Equity Components [Axis] Equity Component [Domain] Common Stock [Member] Common Stock Additional Paid-in Capital [Member] Additional Paid-in Capital Retained Earnings [Member] Accumulated Deficit Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity The value of stock issued during the period upon connection with exercise of warrants. Stock Issue During Period Value In Connection With Exercise Of Warrants Issuance of common stock in connection with exercise of warrants Number of shares issued during the period in connection with exercise of warrants. Stock Issued During Period Shares In Connection With Exercise Of Warrants Issuance of common stock in connection with exercise of warrants (in shares) Purchase of aggregate common stock Stock Issued During Period, Value, New Issues Sale of common stock and warrants and issuance of common stock in connection with exercise of warrants, net of issuance costs Stock Issued During Period, Shares, New Issues Sale of common stock and warrants and issuance of common stock in connection with exercise of warrants, net of issuance costs (in shares) Aggregate of common stock Common stock issued (in shares) Stock Issued During Period, Value, Conversion of Convertible Securities Issuance of common stock in connection with conversion of convertible promissory note Stock Issued During Period, Shares, Conversion of Convertible Securities Issuance of common stock in connection with conversion of convertible promissory note (in shares) The value of stock issued during the period upon connection with exercise of common stock warrants. Stock Issued During Period Value In Connection With Exercise Of Common Stock Warrants Issuance of common stock and common stock warrants in connection with exercise of common stock warrants Number of shares issued during the period in connection with exercise of common stock warrants. Stock Issued During Period Shares In Connection With Exercise Of Common Stock Warrants Issuance of common stock and common stock warrants in connection with exercise of common stock warrants (in shares) APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition Stock-based compensation expense Net Loss Consolidated Statements of Cash Flows Net Cash Provided by (Used in) Operating Activities [Abstract] OPERATING ACTIVITIES Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Depreciation, Depletion and Amortization, Nonproduction Amortization Share-Based Payment Arrangement, Noncash Expense Stock-based compensation Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Accounts Receivable Accounts receivable Increase (Decrease) in Inventories Inventory Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Increase (Decrease) in Other Noncurrent Assets Other assets Increase (Decrease) in Operating Lease Liability Operating lease liabilities Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Accrued Liabilities Accrued expenses Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] INVESTING ACTIVITIES Payments to Acquire Interest in Joint Venture Investment in joint venture Investment in joint venture Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Net cash used in investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] FINANCING ACTIVITIES Proceeds from Issuance of Common Stock Proceeds from the sale of common stock and warrants to purchase common stock, net of issuance costs Proceeds from issuance of stock Payment of Issuance Costs Payment of fees and other issuance costs Proceeds from Warrant Exercises Proceeds from exercise of common stock warrants Proceeds from Issuance of Debt Proceeds from debt Repayments of Debt Repayment of debt Payments of Financing Costs Payment of financing costs Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net increase (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Cash and cash equivalents at end of period Cash and cash equivalents at beginning of period Noncash Investing and Financing Items [Abstract] Supplemental schedule of non-cash financing activities: Debt Conversion, Original Debt, Amount Convertible promissory note converted into common stock Value of fair value of common stock warrants exercised reclassified from liability to equity in a non-cash transactions. Fair Value Of Common Stock Warrants Exercised Reclassified To Equity Fair value of common stock warrants exercised reclassified from warrant liability to equity Represents the amount of common stock included in accounts payable and accrued expenses. Common Stock Issuance Costs Included In Accounts Payable And Accrued Expenses Common stock issuance costs in accounts payable and accrued expenses Represents the amount of common stock and warrant issuance costs included in accounts payable and accrued expenses. Common Stock And Warrant Issuance Costs Included In Accounts Payable And Accrued Expenses Common stock and warrant issuance costs in accounts payable and accrued expenses Reclassification of deferred offering costs against the proceeds of offerings. Reclassification Of Deferred Offering Costs Against Proceeds Of Offering Reclassification of deferred offering costs against ATM proceeds Organization and Description of Business Nature of Operations [Text Block] Organization and Description of Business Liquidity Substantial Doubt about Going Concern [Text Block] Liquidity Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation and Significant Accounting Policies [Text Block] Basis of Presentation and Summary of Significant Accounting Policies Fair Value Measurements Fair Value Disclosures [Text Block] Fair Value Measurements Equity Method Investment Equity Method Investments and Joint Ventures Disclosure [Text Block] Equity Method Investment Accrued Expenses Accounts Payable and Accrued Liabilities Disclosure [Text Block] Accrued Expenses Debt Debt Disclosure [Text Block] Debt Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Common Stock and Stockholders' Equity Equity [Text Block] Common Stock and Stockholders' Equity Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Stock-Based Compensation Segment Information Segment Reporting Disclosure [Text Block] Segment Information Subsequent Events Subsequent Events [Text Block] Subsequent Events Basis of Accounting, Policy [Policy Text Block] Basis of presentation Accounts Receivable [Policy Text Block] Accounts Receivable Inventory, Policy [Policy Text Block] Inventory Use of Estimates, Policy [Policy Text Block] Use of estimates Revenue from Contract with Customer [Policy Text Block] Revenue recognition Cost of Goods and Service [Policy Text Block] Cost of revenues Earnings Per Share, Policy [Policy Text Block] Net loss per share New Accounting Pronouncements, Policy [Policy Text Block] Recently issued accounting pronouncements Schedule of Inventory, Current [Table Text Block] Schedule of Inventory Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of computation of basic and diluted loss per share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of anti-dilutive securities Fair Value, Recurring and Nonrecurring [Table] Financial Instrument [Axis] Financial Instruments [Domain] Represents the debt obligation related to the aggregate unsecured promissory notes. Unsecured promissory notes-aggregate Unsecured promissory notes-aggregate Represents information pertaining to unsecured promissory note March 2026. Unsecured Promissory Note March 2026 [Member] March 2025 Unsecured promissory note March 2026 Note Warrant [Member] Common stock warrants Warrants Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair value Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of assets and liabilities measured at fair value Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Schedule of changes in the fair value of Level 3 liabilities Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Schedule of fair value inputs Schedule of Accrued Liabilities [Table Text Block] Schedule of accrued expenses Schedule of Long-Term Debt Instruments [Table Text Block] Schedule of debt Lease, Cost [Table Text Block] Schedule of lease information Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Schedule of operating lease future minimum payments Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule of warrants outstanding Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Represents information relating to performance based share options. Performance Based Stock Options [Member] Performance-based stock options Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Stock-Based Compensation Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Schedule of stock-based compensation expense Share-Based Payment Arrangement, Option, Activity [Table Text Block] Schedule of stock option activity Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of option assumptions Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of significant expense categories Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument [Line Items] Debt Liquidity Debt Instrument, Fair Value Disclosure Debt, interest, fees Accounts Receivable, Allowance for Credit Loss, Current Accounts receivable, allowance for credit loss, current Inventory, Raw Materials, Net of Reserves Raw materials Inventory, Work in Process, Net of Reserves Work-in-process Inventory, Finished Goods, Net of Reserves Finished goods Amount of decrease in reserve for sales returns. Reserve for Sales Returns, Decrease Reserve for sales returns, decrease Amount of increase in estimated sales return. Reserve for Sales Returns, Increase In Estimated Sales Return Reserve for sales returns, increase in estimated sales return Represents the amount of reversal of reserve for sales returns. Reserve for Sales Returns, Reversal Reserve for sales returns, reversal Net Income (Loss) Available to Common Stockholders, Diluted [Abstract] Numerator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Denominator: Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Convertible Debt Securities [Member] Convertible debt Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive securities Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive securities Debt Instrument, Convertible, Conversion Price Debt conversion rate (in dollars per share) Measurement Frequency [Axis] Measurement Frequency [Domain] Fair Value, Recurring [Member] Recurring Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value, Inputs, Level 3 [Member] Level 3 Financial Liabilities Fair Value Disclosure [Abstract] Liabilities Convertible Debt, Fair Value Disclosures Unsecured convertible promissory note (measured at fair value) Notes Payable, Fair Value Disclosure Unsecured promissory note (measured at fair value) Derivative Liability Warrant liability Derivative Liability, Statement of Financial Position [Extensible Enumeration] Liabilities, Fair Value Disclosure Total Represents information pertaining to unsecured non-convertible promissory note. Unsecured Non-convertible Promissory Note [Member] Unsecured Promissory Note Represents information pertaining to unsecured convertible promissory note. Unsecured Convertible Promissory Note [Member] Unsecured Convertible Promissory Note Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Liabilities fair value changes Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Balance, ending Balance, beginning Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances Issuance of promissory notes Amount of principal and accrued interest converted to common stock classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Principal And Accrued Interest Converted To Common Stock Principal and accrued interest converted to common stock Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Loss from change in fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Repayment Amount of gain (loss) on extinguishment of liability measured at fair value on recurring basis using unobservable input (level 3). Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) on Extinguishment of Debt Loss on extinguishment of debt Fair Value Measurement Inputs and Valuation Techniques [Table] Measurement Input Type [Axis] Measurement Input Type [Domain] Measurement Input, Expected Term [Member] Remaining contractual term of warrants (years) Measurement Input, Price Volatility [Member] Volatility Expected volatility Measurement Input, Risk Free Interest Rate [Member] Risk-free rate Risk-free interest rate Measurement Input, Expected Dividend Rate [Member] Dividend yield Annual dividend yield Measurement Input, Discount Rate [Member] Credit-adjusted discount rate Measurement Input, Share Price [Member] Stock price (in dollars per share) Measurement Input, Credit Spread [Member] Credit spread Represents information pertaining to measurement input using final redemption value. Measurement Input, Final Redemption Value [Member] Final redemption value Represents information pertaining to unsecured convertible promissory note March 2025. Unsecured Convertible Promissory Note March 2025 [Member] March 2025 Note Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair value inputs Amount of maximum principal amount that may be redeemed, repaid, or called by the lender within a specified period under the terms of a debt instrument. Debt Instrument, Redemption Cap Amount Debt instrument, redemption cap amount Debt Instrument, Measurement Input Debt inputs Share Price Share price Warrants and Rights Outstanding, Measurement Input Warrant inputs Equity Method Investment [Table] Legal Entity [Axis] All Entities [Member] Represents information pertaining to Syntone PRC. PRC Joint Venture [Member] Syntone PRC Investment, Name [Axis] Investment, Name [Domain] Represents information pertaining to Syntone joint venture. Syntone [Member] Syntone Schedule of Equity Method Investments [Line Items] Equity Method Investment Equity Method Investment, Ownership Percentage Ownership (as a percent) Equity Method Investment, Aggregate Cost Total capital contributions Amount of capital contribution committed by the company. Capital Contribution Commitment Capital contribution outstanding Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount Maximum loss exposure Employee-related Liabilities, Current Compensation Restructuring Reserve, Current Severance and related costs Accrued Professional Fees, Current Professional fees Represents accrued research and development expenses. Accrued Research And Development Expenses Current Research and development Carrying value as of the balance sheet date of obligations incurred through that date and payable for rebates and sales reserves. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued Rebates and Sales Reserves, Current Accrued rebates Other Accrued Liabilities, Current Other accrued expenses Long-Term Debt, Gross Unsecured convertible promissory note (measured at fair value) Notes and Loans Payable, Current Less: current portion Carrying value as of the balance sheet date of the portion of long-term, uncollateralized debt obligations due within one year or the normal operating cycle, if longer. Unsecured promissory note Unsecured promissory note (measured at fair value) Unsecured Debt, Current Less: current portion Debt Instrument, Face Amount Original principal amount Debt Instrument, Basis Spread on Variable Rate Variable rate (as a percent) Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration] Debt, Weighted Average Interest Rate Total interest rate (as a percent) Debt Conversion, Converted Instrument, Shares Issued Shares converted Debt Instrument, Unamortized Discount Unamortized discount Proceeds from Issuance of Unsecured Debt Proceeds from issuance of unsecured debt Repayments of Convertible Debt Repayments of convertible debt Debt Instrument, Term Debt Instrument, term Debt Instrument, Interest Rate Terms Debt instrument, interest rate terms Debt Instrument, Redemption Period, Start Date Debt instrument, redemption period, start date The exit fees, expressed as percentage of debt instrument. Debt Instrument, Exit Fee, Percentage Exit fee (as a percent) Represents the interest rate annually until paid for the immediately due and payable amounts in case of debt default. Debt Instrument, Debt Default, Accelerated Interest Rate On Immediate Due and Payable Default interest rate (as a percent) Other Commitments [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Information related to fill-finish manufacturing services. Fill-Finish Manufacturing Services [Member] Fill-finish manufacturing Other Commitments [Line Items] Commitments Contractual Obligation Remaining future financial obligations Lessee, Lease, Description [Table] Lessee, Lease, Description [Line Items] Leases Lessee, Operating Lease, Term of Contract Operating lease term Lease, Cost [Abstract] Lease cost: Operating Lease, Cost Operating lease cost Lease, Cost Total lease cost Leases [Abstract] Leases Operating Lease, Liability Total lease obligations Operating lease liabilities Operating Lease, Weighted Average Remaining Lease Term Operating leases, Weighted-average remaining lease term Operating Lease, Weighted Average Discount Rate, Percent Operating leases, Weighted-average discount rate (as a percent) Operating Lease, Payments Operating cash flows from operating leases Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Operating leases Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year 2026 (remaining three months) Lessee, Operating Lease, Liability, to be Paid, Year One 2027 Lessee, Operating Lease, Liability, to be Paid, Year Two 2028 Lessee, Operating Lease, Liability, to be Paid, Year Three 2029 Lessee, Operating Lease, Liability, to be Paid Total undiscounted lease payments Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less: Imputed interest Stock, Class of Stock [Table] Class of Stock [Line Items] Common Stock and Stockholders' Equity Sale of Stock [Axis] Sale of Stock [Domain] Represents information pertaining to at the market offering with H.C. Wainwright & Co., LLC. At Market Offering H.C. Wainwright [Member] H.C. Wainwright ATM Represents information pertaining to at the market offering with BTIG, LLC. At Market Offering BTIG [Member] BTIG ATM Represents the information pertaining to registered direct offering completed in May 2026, including the issuance of common stock and amendment of outstanding warrants. May 2026 Offering [Member] May 2026 Offering Represents the information pertaining to registered direct offering and concurrent private placement completed in April 2026, including the issuance of common stock and warrants. April 2026 Offering [Member] April 2026 Offering The authorized amount of aggregate offering price under the agreement. Aggregate Offering Price, Authorized Aggregate maximum offering price The percentage of aggregate gross proceeds from sale of common stock to be paid as commission under the agreement. Percentage Of Gross Proceeds From Sale Of Common Stock To Be Paid As Commission Common stock sale commission (as a percent) Represents the required notice period for termination of a contractual agreement, indicating the duration of advance written notice that must be provided by either party prior to termination. Termination Notice Period Termination notice period Sale of Stock, Consideration Received on Transaction Net proceeds Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Amount reclassified on additional paid in capital Deferred Costs, Noncurrent Deferred costs Represents the information pertaining to public offering completed in March 2026, including the issuance of common stock and accompanying warrants. March 2026 Offering [Member] March 2026 Offering Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Represents warrants issued to investors in connection with a financing transaction that entitle the holder to purchase the issuer's common stock (or other equity instruments) at a specified exercise price, typically as part of a capital raise or securities offering. Investor Warrants [Member] Investor warrant Represent warrants issued to a placement agent, broker-dealer, or underwriter as compensation for services in connection with a securities offering. These warrants give the holder the right to purchase the issuer's common stock at a fixed exercise price, typically for a specified term Placement Agent Warrants [Member] Placement agent warrants Represents information pertaining to amended warrants. Amended Warrants [Member] Amended Warrants Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Common stock issuable by each warrants (in shares) Shares Issued, Price Per Share Shares issued price (in dollars per share) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Common stock issuable on exercise of warrants (in shares) Warrants to purchase aggregate Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price per share (in dollars per share) Exercise price Amount of incremental costs incurred upon amendment pursuant to warrants or rights. Class of Warrant or Right, Incremental Costs On Amendment Amount of incremental costs Warrants and Rights Outstanding, Term Warrants exercise term Proceeds from Issuance or Sale of Equity Gross proceeds Represents the maximum possible gross cash proceeds an entity could receive if all outstanding warrants are exercised in cash at their contractual exercise price, assuming full conversion and ignoring any probability, timing, or behavioral factors. Potential Proceeds From Warrant Exercise Potential additional gross proceeds Represents common stock warrants that existed prior to January 1, 2025. Class of Warrant or Right, Warrants Existing Prior to 2025 [Member] Existing Warrants Represents common stock warrants with expiration date of November 23, 2026. Twenty Third November Two Thousand Twenty-Six [Member] November 23, 2026 Represents the information related to March 18, 2029. March 18, 2029 Represents common stock warrants with expiration date of April 15, 2029. Fifteenth April Two Thousand Twenty Nine [Member] April 15, 2029 Represents first set of common stock warrants with expiration date of January 17, 2030. Seventeen January Two Thousand Thirty, One [Member] January 17, 2030 Represents second set of common stock warrants with expiration date of January 17, 2030. Seventeen January Two Thousand Thirty, Two [Member] January 17, 2030 Represents third set of common stock warrants with expiration date of January 17, 2030. Seventeen January Two Thousand Thirty, Three [Member] January 17, 2030 Represents first set of common stock warrants with expiration date of May 27, 2030. Twenty Seventh May Two Thousand Thirty, One [Member] May 27, 2030 Represents second set of common stock warrants with expiration date of May 27, 2030. Twenty Seventh May Two Thousand Thirty, Two [Member] May 27, 2030 Represents first set of common stock warrants with expiration date of March 25, 2031. Twenty Five March, Two thousand Thirty One, One [Member] March 25, 2031 Represents second set of common stock warrants with expiration date of March 25, 2031. Twenty Five March, Two thousand Thirty One, Two [Member] March 25, 2031 Statistical Measurement [Axis] Statistical Measurement [Domain] Minimum [Member] Minimum Maximum [Member] Maximum Represents the first beneficial ownership restriction for the warrant holder to not exercise. Beneficial Ownership One For The Holder To Not Exercise Warrant Beneficial ownership exercise restriction, one (as a percent) Represents the second beneficial ownership restriction for the warrant holder to not exercise. Beneficial Ownership Two For The Holder To Not Exercise Warrant Beneficial ownership exercise restriction, two (as a percent) Represents the third beneficial ownership restriction for the warrant holder to not exercise. Beneficial Ownership Three For The Holder To Not Exercise Warrant Beneficial ownership exercise restriction, three (as a percent) Represents the number of days that must elapse after written notice is provided before the change in ownership limitation becomes effective. Ownership Limit Change, Waiting Period Number of days Threshold stock price per share that must be met for the consecutive days to trigger the company's right to force warrant exercise. Stock Price Threshold Per Share Stock price threshold per share Number of consecutive days within which specific conditions must be satisfied. Number Of Consecutive Days Number Of Consecutive days Represents the percentage of aggregate number of Warrants the entity may require holders to exercise upon satisfaction of certain conditions. Percentage Of Aggregate Number Of Warrants The Holders May Require To Exercise Upon Satisfaction Of Certain Conditions Warrant holders exercise under certain conditions (as a percent) Number of securities into which the class of warrant or right expired. Class of Warrant or Right, Number of Securities Called by Warrants or Rights, Expired Aggregate of common stock expired Weighted average exercise price per share or per unit of warrants or rights expired. Class of Warrant or Right, Weighted Average Exercise Price of Warrants Expired Weighted average exercise price expired The cash inflow associated with the amount received from holders exercising their stock warrants after deducting expenses. Proceeds From Warrant Exercises, Net Aggregate net proceeds Plan Name [Axis] Plan Name [Domain] Represents the 2024 Equity Incentive Plan. Equity Incentive Plan, 2024 [Member] 2024 Equity Incentive Plan Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Share-based stock authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Share-based stock available for grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Term of award Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Domain] Research and Development Expense [Member] Research and development General and Administrative Expense [Member] General and administrative Share-Based Payment Arrangement, Expense Stock-based compensation expense Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Balance, Ending (in shares) Balance, Beginning (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Vested and exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Balance, Ending (in dollars per share) Balance, Beginning (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Expired (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Vested and exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Weighted Average Remaining Contractual Term (Years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Balance-Remaining contractual term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Vested and exercisable -Remaining contractual term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Aggregate intrinsic value, Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Grant date fair value of options (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Expected term (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expected dividend yield Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Unrecognized compensation exercise period Schedule of Segment Reporting Information, by Segment [Table] Segments [Axis] Segments [Domain] Represents information pertaining to segment development and commercialization of ONS-5010/LYTENAVA. Development And Commercialization Of Ons-5010 Or Lytenava [Member] Development and commercialization of ONS-5010/LYTENAVA Segment Reporting Information [Line Items] Segment Information Number of Reportable Segments Number of reportable segment Segment Reporting Information, Income (Loss) before Income Taxes [Abstract] Segment loss before income taxes Research and Development Expense [Abstract] Research and development expenses Amount of ONS-5010/LYTENAVA development incurred during the period included in research and development expenses. Research and Development Expense, Ons-5010 Or Lytenava Development ONS-5010/LYTENAVA development Amount of compensation and related benefits incurred during the period included in research and development expenses. Research and Development Expense, Compensation And Related Benefits Compensation and related benefits Amount of stock-based compensation incurred during the period included in research and development expenses. Research and Development Expense, Stock Based Compensation Stock-based compensation Other Research and Development Expense Other research and development Selling, General and Administrative Expense [Abstract] Selling, general and administrative expenses Amount of professional fees incurred during the period included in selling general and administrative expenses. Selling, General and Administrative Expense, Professional Fees Professional fees Amount of compensation and related benefits incurred during the period included in selling general and administrative expenses. Selling, General and Administrative Expense, Compensation And Related Benefits Compensation and related benefits Amount of stock-based compensation incurred during the period included in selling general and administrative expenses. Selling, General and Administrative Expense, Stock Based Compensation Stock-based compensation Amount of Europe commercial expenses incurred during the period included in selling general and administrative expenses. Selling, General and Administrative Expense, Europe Commercial Expenses Europe commercial expenses Amount of facilities, fees and other related costs incurred during the period included in selling general and administrative expenses. Selling, General and Administrative Expense, Facilities, Fees And Other Related Costs Facilities, fees and other related costs Segment Reporting, Other Segment Item, Amount Other segment items Segment Reporting, Other Segment Item, Composition, Description Segment Reporting, Other Segment Item, Composition, Description Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent Events Related and Nonrelated Parties [Axis] Related and Nonrelated Parties [Domain] Beneficial Owner [Member] Beneficial owner Chief Executive Officer [Member] Chief Executive Officer Chief Financial Officer [Member] Chief Financial Officer Further sale of stock by a private company to the public. August 2026 Follow-On Offering [Member] August 2026 Follow-On Offering Over-Allotment Option [Member] Underwriter Subsidiary, Sale of Stock [Line Items] Subsequent Events Period to exercise the over-allotment option, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Over Allotment Period Period to exercise the underwriters Maximum number of additional shares offered to purchase by the underwriters during the option period. Maximum Number Of Additional Shares Offered For Purchase Maximum number of additional shares Represent the warrants purchased which will give the right to maximum number of additional shares of common stock for the underwriter upon exercise the over allotment option. Maximum Class of Warrant or Right, Number of Securities Called by Warrants or Rights, Purchased Number of additional shares of common stock for the underwriter